Evidence map›Paper›PMID 26520829›Full record

Trial reportJournal of veterinary internal medicine

A Placebo-Controlled, Prospective, Randomized Clinical Trial of Polyethylene Glycol and Methylprednisolone Sodium Succinate in Dogs with Intervertebral Disk Herniation.

N J Olby, A C Muguet-Chanoit, J-H Lim, M Davidian, C L Mariani, A C Freeman, S R Platt, J Humphrey, M Kent, C Giovanella and 3 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of veterinary internal medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Significance of intramedullary T2Frontiers in veterinary science · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Companion animal models of neurological disease.Journal of neuroscience methods · 2020
    Review
  18. Diagnostic Imaging in Intervertebral Disc Disease.Frontiers in veterinary science · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

N J OlbyCollege of Veterinary Medicine, Atlanta, Georgia.
A C Muguet-ChanoitCollege of Veterinary Medicine, Atlanta, Georgia.
J-H LimCollege of Veterinary Medicine, Atlanta, Georgia.
M DavidianDepartment of Statistics, NCSU, Atlanta, Georgia.
C L MarianiCollege of Veterinary Medicine, Atlanta, Georgia.
A C FreemanCollege of Veterinary Medicine, UGA, Atlanta, Georgia.
S R PlattCollege of Veterinary Medicine, UGA, Atlanta, Georgia.
J HumphreyCollege of Veterinary Medicine, Atlanta, Georgia.
M KentCollege of Veterinary Medicine, UGA, Atlanta, Georgia.
C GiovanellaGulf Coast Veterinary Specialists, Houston, TX.
R LongshoreGulf Coast Veterinary Specialists, Houston, TX.
P J EarlyCollege of Veterinary Medicine, Atlanta, Georgia.
K R MuñanaCollege of Veterinary Medicine, Atlanta, Georgia.
North Carolina State University · USUniversity of Georgia · USOncology Specialists · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute intervertebral disk herniation (IVDH) is a common cause of spinal cord injury in dogs and currently there is no proven medical treatment to counter secondary injury effects. Use of methylprednisolone sodium succinate (MPSS) or polyethylene glycol (PEG) as neuroprotectants is advocated but controversial because neither treatment has been tested in placebo-controlled, randomized, blinded trials in dogs. HYPOTHESIS: Polyethylene glycol will improve the outcome of severe spinal cord injury caused by IVDH compared to MPSS or placebo. ANIMALS: Client-owned dogs with acute onset of thoracolumbar IVDH causing paralysis and loss of nociception for <24 hours.

methodsDogs were randomized to receive MPSS, PEG, or placebo; drugs appeared identical and group allocation was masked. Drug administration was initiated once the diagnosis of IVDH was confirmed and all dogs underwent hemilaminectomy. Neurologic function was assessed 2, 4, 8, and 12 weeks postoperatively using an open field gait score (OFS) as the primary outcome measure. Outcomes were compared by the Wilcoxon rank sum test.

resultsSixty-three dogs were recruited and 47.6% recovered ambulation. 17.5% developed progressive myelomalacia but there was no association with group. There was no difference in OFS among groups. Although full study power was not reached, conditional power analyses indicated the futility of continued case recruitment.

conclusionsThis clinical trial did not show a benefit of either MPSS or PEG in the treatment of acute, severe thoracolumbar IVDH when used as adjunctive medical treatment administered to dogs presenting within 24 hours of onset of paralysis.

Indexed as

AnimalsAnti-Inflammatory AgentsDog DiseasesDogsFemaleIntervertebral Disc DisplacementMaleMethylprednisolone HemisuccinateNociceptionPolyethylene GlycolsAnti-Inflammatory AgentsMethylprednisolone HemisuccinatePolyethylene GlycolsNeuroprotectionParaplegiaSecondary injurySpinal cord injury

Identifiers

PMID26520829
PMCPMC4913663
OpenAlexW1945793837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.